CenterBook Partners’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,055
Closed -$216K 383
2023
Q4
$216K Sell
6,055
-11,534
-66% -$429K 0.03% 374
2023
Q3
$770K Buy
+17,589
New +$858K 0.1% 272
2023
Q2
Sell
-5,193
Closed -$215K 414
2023
Q1
$215K Sell
5,193
-10,607
-67% -$440K 0.03% 370
2022
Q4
$701K Buy
15,800
+8,913
+129% +$372K 0.12% 246
2022
Q3
$269K Buy
+6,887
New +$315K 0.05% 346

Other funds holding ATRC

CenterBook Partners's ATRC Position: Q1 2024 in Review

CenterBook Partners sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 6,055 shares — an estimated $216K sold.

CenterBook Partners first reported a position in ATRC in Q3 2022 and held it in 5 quarters. The position peaked at $770K in Q3 2023. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.

  • CenterBook Partners reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
  • CenterBook Partners sold 6,055 AtriCure shares in Q1 2024, an estimated $216K.
  • CenterBook Partners first reported a position in AtriCure in Q3 2022 and held it in 5 quarters.
  • CenterBook Partners's AtriCure position peaked at $770K in Q3 2023.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.

Based on CenterBook Partners's 13F filing for Q1 2024, filed 10 May 2024.